vs
Side-by-side financial comparison of Axsome Therapeutics, Inc. (AXSM) and PATHWARD FINANCIAL, INC. (CASH). Click either name above to swap in a different company.
Axsome Therapeutics, Inc. is the larger business by last-quarter revenue ($196.0M vs $173.1M, roughly 1.1× PATHWARD FINANCIAL, INC.). PATHWARD FINANCIAL, INC. runs the higher net margin — 20.3% vs -14.6%, a 34.9% gap on every dollar of revenue. On growth, Axsome Therapeutics, Inc. posted the faster year-over-year revenue change (65.0% vs -0.2%). PATHWARD FINANCIAL, INC. produced more free cash flow last quarter ($104.1M vs $-18.7M). Over the past eight quarters, Axsome Therapeutics, Inc.'s revenue compounded faster (61.7% CAGR vs -18.0%).
Jazz Pharmaceuticals plc is a global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California, United States and is now headquartered in Dublin, Ireland.
Pathward Financial, Inc. is a U.S.-based banking and financial services company. It adopted its current name in 2022 after its parent, Meta Financial Group, sold the "Meta" trademark to Meta Platforms.
AXSM vs CASH — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $196.0M | $173.1M |
| Net Profit | $-28.6M | $35.2M |
| Gross Margin | — | — |
| Operating Margin | -13.8% | 24.6% |
| Net Margin | -14.6% | 20.3% |
| Revenue YoY | 65.0% | -0.2% |
| Net Profit YoY | 61.9% | 11.9% |
| EPS (diluted) | $-0.55 | $1.57 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $196.0M | $173.1M | ||
| Q3 25 | $171.0M | $186.7M | ||
| Q2 25 | $150.0M | $195.8M | ||
| Q1 25 | $121.5M | $274.8M | ||
| Q4 24 | $118.8M | $182.6M | ||
| Q3 24 | $104.8M | $179.5M | ||
| Q2 24 | $87.2M | $188.6M | ||
| Q1 24 | $75.0M | $257.6M |
| Q4 25 | $-28.6M | $35.2M | ||
| Q3 25 | $-47.2M | $38.8M | ||
| Q2 25 | $-48.0M | $42.1M | ||
| Q1 25 | $-59.4M | $75.0M | ||
| Q4 24 | $-74.9M | $30.0M | ||
| Q3 24 | $-64.6M | $33.5M | ||
| Q2 24 | $-79.3M | $44.9M | ||
| Q1 24 | $-68.4M | $69.9M |
| Q4 25 | -13.8% | 24.6% | ||
| Q3 25 | -27.0% | 25.9% | ||
| Q2 25 | -24.5% | 24.1% | ||
| Q1 25 | -46.9% | 33.2% | ||
| Q4 24 | -61.1% | 19.8% | ||
| Q3 24 | -59.8% | 20.9% | ||
| Q2 24 | -89.5% | 27.1% | ||
| Q1 24 | -89.7% | 33.8% |
| Q4 25 | -14.6% | 20.3% | ||
| Q3 25 | -27.6% | 20.8% | ||
| Q2 25 | -32.0% | 21.5% | ||
| Q1 25 | -48.9% | 27.3% | ||
| Q4 24 | -63.1% | 16.4% | ||
| Q3 24 | -61.7% | 18.7% | ||
| Q2 24 | -91.0% | 23.8% | ||
| Q1 24 | -91.1% | 27.1% |
| Q4 25 | $-0.55 | $1.57 | ||
| Q3 25 | $-0.94 | $1.69 | ||
| Q2 25 | $-0.97 | $1.81 | ||
| Q1 25 | $-1.22 | $3.14 | ||
| Q4 24 | $-1.54 | $1.23 | ||
| Q3 24 | $-1.34 | $1.34 | ||
| Q2 24 | $-1.67 | $1.78 | ||
| Q1 24 | $-1.44 | $2.74 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $322.9M | $331.2M |
| Total DebtLower is stronger | — | $33.5M |
| Stockholders' EquityBook value | $88.3M | $854.5M |
| Total Assets | $689.8M | $7.6B |
| Debt / EquityLower = less leverage | — | 0.04× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $322.9M | $331.2M | ||
| Q3 25 | $325.3M | $120.6M | ||
| Q2 25 | $303.0M | $258.3M | ||
| Q1 25 | $300.9M | $254.2M | ||
| Q4 24 | $315.4M | $597.4M | ||
| Q3 24 | $327.3M | $158.3M | ||
| Q2 24 | $315.7M | $298.9M | ||
| Q1 24 | $331.4M | $347.9M |
| Q4 25 | — | $33.5M | ||
| Q3 25 | — | $33.5M | ||
| Q2 25 | — | $33.4M | ||
| Q1 25 | — | $33.4M | ||
| Q4 24 | — | $33.4M | ||
| Q3 24 | — | $33.4M | ||
| Q2 24 | — | $33.3M | ||
| Q1 24 | — | $33.4M |
| Q4 25 | $88.3M | $854.5M | ||
| Q3 25 | $73.7M | $858.0M | ||
| Q2 25 | $73.1M | $819.0M | ||
| Q1 25 | $53.2M | $814.7M | ||
| Q4 24 | $57.0M | $758.3M | ||
| Q3 24 | $92.9M | $822.5M | ||
| Q2 24 | $102.9M | $748.4M | ||
| Q1 24 | $144.0M | $719.5M |
| Q4 25 | $689.8M | $7.6B | ||
| Q3 25 | $669.3M | $7.2B | ||
| Q2 25 | $639.8M | $7.2B | ||
| Q1 25 | $596.7M | $7.0B | ||
| Q4 24 | $568.5M | $7.6B | ||
| Q3 24 | $561.5M | $7.5B | ||
| Q2 24 | $548.2M | $7.5B | ||
| Q1 24 | $545.7M | $7.4B |
| Q4 25 | — | 0.04× | ||
| Q3 25 | — | 0.04× | ||
| Q2 25 | — | 0.04× | ||
| Q1 25 | — | 0.04× | ||
| Q4 24 | — | 0.04× | ||
| Q3 24 | — | 0.04× | ||
| Q2 24 | — | 0.04× | ||
| Q1 24 | — | 0.05× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-18.7M | $108.3M |
| Free Cash FlowOCF − Capex | $-18.7M | $104.1M |
| FCF MarginFCF / Revenue | -9.6% | 60.1% |
| Capex IntensityCapex / Revenue | 0.0% | 2.4% |
| Cash ConversionOCF / Net Profit | — | 3.08× |
| TTM Free Cash FlowTrailing 4 quarters | $-93.9M | $616.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-18.7M | $108.3M | ||
| Q3 25 | $1.0M | $303.7M | ||
| Q2 25 | $-32.4M | $30.4M | ||
| Q1 25 | $-43.4M | $188.3M | ||
| Q4 24 | $-26.2M | $-71.7M | ||
| Q3 24 | $-18.6M | $143.1M | ||
| Q2 24 | $-30.1M | $113.2M | ||
| Q1 24 | $-53.5M | $203.0M |
| Q4 25 | $-18.7M | $104.1M | ||
| Q3 25 | $988.0K | $300.3M | ||
| Q2 25 | $-32.4M | $27.7M | ||
| Q1 25 | $-43.7M | $184.7M | ||
| Q4 24 | $-26.2M | $-73.8M | ||
| Q3 24 | $-18.7M | $138.8M | ||
| Q2 24 | $-30.2M | $111.0M | ||
| Q1 24 | $-53.6M | $201.3M |
| Q4 25 | -9.6% | 60.1% | ||
| Q3 25 | 0.6% | 160.9% | ||
| Q2 25 | -21.6% | 14.1% | ||
| Q1 25 | -36.0% | 67.2% | ||
| Q4 24 | -22.1% | -40.4% | ||
| Q3 24 | -17.9% | 77.3% | ||
| Q2 24 | -34.6% | 58.8% | ||
| Q1 24 | -71.4% | 78.1% |
| Q4 25 | 0.0% | 2.4% | ||
| Q3 25 | 0.0% | 1.8% | ||
| Q2 25 | 0.0% | 1.4% | ||
| Q1 25 | 0.3% | 1.3% | ||
| Q4 24 | 0.0% | 1.1% | ||
| Q3 24 | 0.1% | 2.4% | ||
| Q2 24 | 0.1% | 1.2% | ||
| Q1 24 | 0.1% | 0.7% |
| Q4 25 | — | 3.08× | ||
| Q3 25 | — | 7.83× | ||
| Q2 25 | — | 0.72× | ||
| Q1 25 | — | 2.51× | ||
| Q4 24 | — | -2.39× | ||
| Q3 24 | — | 4.27× | ||
| Q2 24 | — | 2.52× | ||
| Q1 24 | — | 2.90× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AXSM
Segment breakdown not available.
CASH
| Consumer | $103.0M | 59% |
| Payment Card And Deposit Fees | $30.1M | 17% |
| Other | $24.2M | 14% |
| Rental Income | $11.6M | 7% |
| Commercial | $4.2M | 2% |
